GeneFluidics, Inc.
PrivateLast Round
Series A
Nov 4, 2022
Total Funding Raised
$15.78M
Company Overview
GeneFluidics, Inc. is a biotechnology company that develops rapid molecular diagnostic platforms for the detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneFluidics, Inc. Comparables
Compare GeneFluidics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avails Medical | 80% | |
| Pattern Bioscience | 80% | |
| QuantaMatrix Inc. | 79% |
GeneFluidics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 4, 2022 | ||||
| Grant | Sep 30, 2021 | ||||
| Grant | Sep 30, 2020 | ||||
| Grant | Sep 30, 2019 | ||||
| Grant | Sep 30, 2018 | ||||
Grant | Sep 30, 2017 |
GeneFluidics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Bradbury Asset Management (Hong Kong) Limited | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2022
Raised Series A round with Bradbury Asset Management.
- Sep 30, 2021
$962K grant received from U.S. Department of Health and Human Services.
GeneFluidics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GeneFluidics, Inc.'s valuation, stock price, and market status.
Is GeneFluidics, Inc. a public or private company?
GeneFluidics, Inc. is a private company.
What is the current stock price of GeneFluidics, Inc.?
GeneFluidics, Inc. is a private company with no public stock price. Caplight tracks GeneFluidics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is GeneFluidics, Inc. worth (valuation)?
Valuation information for GeneFluidics, Inc. is not publicly available.
Can I buy GeneFluidics, Inc. stock?
GeneFluidics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GeneFluidics, Inc.'s last funding round?
GeneFluidics, Inc.'s most recent funding round was Series A on November 4, 2022.
Who are the main investors in GeneFluidics, Inc.?
Key investors in GeneFluidics, Inc. include U.S. Department of Health and Human Services, Bradbury Asset Management (Hong Kong) Limited.
Will GeneFluidics, Inc. IPO soon?
No public IPO plans have been announced for GeneFluidics, Inc..
How can I track GeneFluidics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GeneFluidics, Inc.'s secondary market activity and sign up for updates.